These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 9873175)

  • 1. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
    Gupta AK; Williams JV; Zaman M; Singh J
    Med Mycol; 2009 Dec; 47(8):796-801. PubMed ID: 19212895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinea capitis in children: A single-institution retrospective review from 2011 to 2019.
    Zhi H; Shen H; Zhong Y; Sang B; Lv W; Li Q; Liu Z; Xia X
    Mycoses; 2021 May; 64(5):550-554. PubMed ID: 33455042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.
    Abastabar M; Babaei M; Mohammadi R; Valadan R; Javidnia J; Zaedi A; Aghili SR; Haghani I; Khojasteh S; Reazaei-Matehkolaei A; Kiasat N; Hesari KK; Ghasemi Z; Azish M; Zarrinfar H; Taghizadeh-Armaki M; Keikha N; Kharazi M; Khodadadi H; Hedayati MT; Shokohi T
    Mycopathologia; 2023 Oct; 188(5):449-460. PubMed ID: 35980496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea capitis caused by Microsporum canis: A case study of three family members in India, a non-endemic region.
    Capoor MR; Sharma S; Goenka S; Das S; Rudramurthy SM; Khunger N; Kamra N
    Indian J Med Microbiol; 2024; 50():100621. PubMed ID: 38885904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinea capitis in adults.
    Aste N; Pau M; Biggio P
    Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective two-centre study on prepubertal children with Tinea capitis in Korea.
    Lee WJ; Lee EH; Bang YJ; Jun JB
    Mycoses; 2020 Jan; 63(1):52-57. PubMed ID: 31596519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tinea capitis: two years experience in a paediatric hospital of Buenos Aires, Argentina].
    Santos PE; Córdoba S; Rodero LL; Carrillo-Muñoz AJ; Lopardo HA
    Rev Iberoam Micol; 2010 Jun; 27(2):104-6. PubMed ID: 20346290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran.
    Allahdadi M; Hajihossein R; Kord M; Rahmati E; Amanloo S; Didehdar M
    J Mycol Med; 2019 Apr; 29(1):19-23. PubMed ID: 30660447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tinea capitis caused by Microsporum canis treated with terbinafine.
    Aste N; Pau M
    Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.